Acadia Pharmaceuticals Inc
2013 Q4 - 2025 Q4 (28 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/12/2026 | 3,437 | 0.0% | 128,689 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 2,746 | 0.0% | 128,689 | 9/30/2025 |
| 2025 Q2 | 8/13/2025 | 2,854 | 0.0% | 132,305 | 6/30/2025 |
| 2025 Q1 | 5/12/2025 | 574 | 0.0% | 34,581 | 3/31/2025 |
| 2024 Q4 | 2/10/2025 | 635 | 0.0% | 34,581 | 12/31/2024 |
| 2024 Q3 | 11/8/2024 | 532 | 0.0% | 34,581 | 9/30/2024 |
| 2024 Q2 | 8/8/2024 | 562 | 0.0% | 34,581 | 6/30/2024 |
| 2024 Q1 | 5/8/2024 | 751 | 0.0% | 39,881 | 3/31/2024 |
| 2023 Q4 | 2/9/2024 | 1,083 | 0.0% | 34,581 | 12/31/2023 |
| 2023 Q3 | 11/8/2023 | 721 | 0.0% | 34,581 | 9/30/2023 |
| 2023 Q2 | 8/11/2023 | 824 | 0.0% | 34,401 | 6/30/2023 |
| 2023 Q1 | 6/14/2023 | 751 | 0.0% | 39,881 | 3/31/2023 |
| 2022 Q4 | 6/14/2023 | 635 | 0.0% | 39,881 | 12/31/2022 |
| 2022 Q3 | 11/8/2022 | 779 | 0.0% | 47,611 | 9/30/2022 |
| 2022 Q2 | 8/5/2022 | 671 | 0.0% | 47,611 | 6/30/2022 |
| 2022 Q1 | 5/6/2022 | 1,153 | 0.0% | 47,611 | 3/31/2022 |
| 2021 Q4 | 2/8/2022 | 1,111 | 0.0% | 47,611 | 12/31/2021 |
| 2021 Q3 | 11/8/2021 | 791 | 0.0% | 47,611 | 9/30/2021 |
| 2021 Q2 | 8/10/2021 | 1,161 | 0.0% | 47,611 | 6/30/2021 |
| 2021 Q1 | 5/10/2021 | 3,107 | 0.0% | 120,440 | 3/31/2021 |
| 2020 Q4 | 2/8/2021 | 6,789 | 0.0% | 126,990 | 12/31/2020 |
| 2020 Q3 | 11/9/2020 | 5,377 | 0.0% | 130,358 | 9/30/2020 |
| 2020 Q2 | 8/7/2020 | 6,278 | 0.0% | 129,528 | 6/30/2020 |
| 2020 Q1 | 5/5/2020 | 2,333 | 0.0% | 55,223 | 3/31/2020 |
| 2019 Q4 | 2/3/2020 | 2,362 | 0.0% | 55,223 | 12/31/2019 |
| 2014 Q2 | 8/7/2014 | 1,232 | 0.0% | 54,557 | 6/30/2014 |
| 2014 Q1 | 4/24/2014 | 838 | 0.0% | 34,426 | 3/31/2014 |
| 2013 Q4 | 2/5/2014 | 634 | 0.0% | 25,356 | 12/31/2013 |